$550 million funding for a potential new TB vaccine in over 100 years
Wellcome and the Bill & Melinda Gates Foundation have announced funding for the advancement of a tuberculosis (TB) vaccine candidate called M72/AS01E (M72) through a Phase III clinical trial. The Phase III clinical trial for M72, which is estimated to cost around $550 million, will be funded by Wellcome (up to $150 million) and the…